If you have trouble viewing this document, click here to view it as a webpage.

2026 Legislative Update


February 13, 2026



Paul D. Seltzer, DO, Legislative Chair

Michelle W. Larson, CEO

Jason D. Winn, Esq.

Chris Lyon, Esq.

Summary

Week Five at the Capitol was marked by significant health policy activity against a backdrop of heightened advocacy presence during Dade Days and Nonprofit Day. The Senate advanced a series of substantive measures addressing newborn screening requirements, congenital disease education, Medicaid financing oversight, enhanced transparency for managed care plans and pharmacy benefit managers, and modernization of professional licensure standards, including regulatory reforms related to naturopathic medicine.



Concurrently, the Department of Health initiated formal rulemaking to modify eligibility criteria for Florida’s AIDS Drug Assistance Program in response to projected funding constraints. The proposal has generated legal challenges and opened a public comment period, positioning the issue as a consequential administrative development with potential implications for patient access and program administration.


With substantive Senate committees having concluded meetings, legislation not heard is now unlikely to advance, signaling a pivotal transition in the legislative session as priority health initiatives move forward and remaining proposals narrow.


For the full legislative session week 5 update, please click the red button below.


Share Your Legislative Session Photos

Help us highlight member involvement during the Florida legislative session! If you attend hearings, meet with legislators, or participate in session-related events, we invite you to share your photos with us. These images help demonstrate the strength and engagement of our members and may be featured in future FOMA publications.


Please submit photos to fomapr@foma.org.

pac-donation-logo-web_2_orig image